Regeneron Pharmaceuticals, Inc., Sanofi (France) Drug Tames Eczema In Phase 2b Trial

Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis Results from Earlier Clinical Trials Published Today in the New England Journal of Medicine TARRYTOWN, N.Y. and PARIS, July 9, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive ... (more)

http://ift.tt/1oK4CWY